Investor Presentaiton
We have the right strategy at the right time to develop
transformational medicines & change patients' lives
Causal human biology
Path to improve R&D productivity
Use of human data for rigorous target
validation in drug discovery
Build on our strength in five
core therapeutic areas
•
Matching modality to mechanism
Diverse portfolio of modalities
supplemented with Al and ML
Diverse modalities, including
Targeted Protein Degradation
and Cell Therapy
88
Path to clinical proof-of-concept
Enable mechanistic models for dose,
schedule, and patient selection
All enabled by translational
insights, computational
science and BD partnerships
Ill Bristol Myers Squibb™
.
Increase number of
INDs with
transformational
potential
Increase success in
clinical
development
Not for Product Promotional Use
50View entire presentation